Brief: Modus Therapeutics Resolves On Directed Share Issue Of 20 Million Shares
04/09/2026 06:57
BRIEF-Modus Therapeutics Resolves On Directed Share Issue Of 20 Million Shares Sept 4 (Reuters) - Modus Therapeutics Holding AB MODTX.ST:
SAID ON THURSDAY RESOLVES ON DIRECTED NEW ISSUE OF 20 MILLION SHARES
SUBSCRIPTION PRICE IS SET AT SEK 0.38 PER SHARE TO RAISE SEK 7.6 MILLION BEFORE TRANSACTION COSTS
Source text for Workspace: nMFN75bvFZ
Further company coverage: MODTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Modus Therapeutics Holding AB
See all newsBrief: Modus Therapeutics Temporarily Pauses Enrollment In Phase IIa Study Of Sevuparin In CKD With Anemia
Brief: Modus Gets SEK 0.13 Mln Through Exercise Of Warrants
Brief: Modus Therapeutics Resolves On Directed Share Issue Of 20 Million Shares
Sweden's Modus Therapeutics narrows Q2 net loss, extends financing
Brief: Modus Therapeutics Q2 Net Income SEK -4.645 Million